ALLOZYNE Announces Completion Of Phase IA Trial By AZ01, A Long Lasting Interferon For Treatment Of Relapsing Remitting Multiple Sclerosis

Links shared publicly online about this topic.

  • 584
    total visits

ALLOZYNE Announces Completion Of Phase IA Trial By AZ01, A Long Lasting Interferon For Treatment Of Relapsing Remitting Multiple Sclerosis

medicalnewstoday.com —

ALLOZYNE, Inc. announced, the completion of its first Phase IA clinical trial in healthy individuals for AZ01, a PEGylated form of human interferon beta-1b which is being developed for the treatme

View full resource at medicalnewstoday.com

Tags: Multiple Sclerosis, Multiple Sclerosis Medication, Clinical Trial, Betaseron, Betaferon

  • Share

Most Recently Shared on January 14, 2011 at 1:50 am By:

MS_Wisdom2 OrganizedWisdom MS

ALLOZYNE Announces Completion Of Phase IA Trial By AZ01, A Long Lasting Interferon β For Treatment Of Relapsi... http://bit.ly/ga2RPr

1 year ago...

Reply

Retweet

Favorite

Also Shared By:

MNT Multiple Scl MNT Multiple Scl

Advertisement